L. Tauchmanovà

发表

Antiphospholipid syndrome, adrenal failure, dilated cardiomyopathy and chronic hepatitis: an unusual manifestation of multiorgan autoimmune injury?

L. del Viscovo, A. De Bellis, A. Bellis, 1998, European journal of endocrinology.

Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender

M. C. Savanelli, A. Colao, S. Savastano, 2008, Journal of endocrinological investigation.

An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer.

S. Venuta, V. Barbieri, E. Ricevuto, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Imbalance of the Osteoprotegerin/RANKL Ratio in Bone Marrow Microenvironment After Allogeneic Hemopoietic Stem Cell Transplantation

C. Carella, A. Risitano, A. Colao, 2006, Transplantation.

Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing’s syndrome

A. Colao, G. Lombardi, E. Guerra, 2009, Journal of endocrinological investigation.

Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease

F. Manguso, F. Orio, A. Colao, 2005, Osteoporosis International.

Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation.

A. Risitano, A. Colao, G. Lombardi, 2002, The Journal of clinical endocrinology and metabolism.

Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women

G. Bifulco, C. Nappi, A. Colao, 2007, Menopause.

Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism.

G. Lupoli, B. Trimarco, V. Nuzzo, 2002, European journal of endocrinology.

Long-acting pasireotide improves clinical signs and quality of life in Cushing’s disease: results from a phase III study

J. Schopohl, Y. Li, A. Barkan, 2020, Journal of Endocrinological Investigation.

Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study

M. Fleseriu, M. Roughton, J. Newell-Price, 2019, Clinical endocrinology.

Prediction of response to growth hormone treatment in pre-pubertal children with growth hormone deficiency

A. Pasquino, G. Saggese, A. Falorni, 2011 .

REVIEW: Bone Loss and Its Management in Long-Term Survivors from Allogeneic Stem Cell Transplantation

A. Colao, G. Lombardi, B. Rotoli, 2007 .

Bone loss and its management in long-term survivors from allogeneic stem cell transplantation.

A. Colao, G. Lombardi, B. Rotoli, 2007, The Journal of clinical endocrinology and metabolism.

Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism.

M. Salvatore, M. D. De Martino, A. Colao, 2007, European journal of endocrinology.

Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status.

M. Salvatore, M. D. De Martino, A. Colao, 2006, The Journal of clinical endocrinology and metabolism.

Disorders of endocrine, reproductive and skeletal systems following allogeneic or autologous stem cell transplantation for hematological malignancies in adults

L. Tauchmanovà, 2006 .

Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies

G. Bifulco, F. Orio, G. Lombardi, 2003, Osteoporosis International.

Baseline characteristics of the population enrolled in the Italian Observational Study on Severe Osteoporosis (ISSO).

S. Adami, S. Migliaccio, G. Iolascon, 2011, Clinical and Experimental Rheumatology.

Accelerated Bone Mass Senescence After Hematopoietic Stem Cell Transplantation

M. Sessa, C. Selleri, L. Pezzullo, 2013, Translational medicine @ UniSa.

Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial.

C. Nappi, F. Orio, A. Colao, 2002, Human reproduction.

Evaluation of skeletal status by quantitative ultrasonometry in postmenopausal women without known risk factors for osteoporosis

C. Nappi, C. di Carlo, L. Tauchmanovà, 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review

C. Nappi, A. Colao, G. Lombardi, 2007, Menopause.

Endocrine disorders during the first year after autologous stem-cell transplant.

F. Orio, A. Colao, G. Lombardi, 2005, The American journal of medicine.

Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.

M. Boscaro, M. Yamada, M. Roughton, 2018, The lancet. Diabetes & endocrinology.

Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: A case of idiopathic hirsutism?

F. Orio, A. Colao, S. Savastano, 2004, Journal of endocrinological investigation.

Growth hormone excess with onset in adolescence: clinical appearance and long‐term treatment outcome

A. Colao, S. Savastano, G. Lombardi, 2007, Clinical endocrinology.

Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.

B. Biondi, V. Nuzzo, G. Lombardi, 2002, The Journal of clinical endocrinology and metabolism.

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome.

L. Nardo, F. Manguso, F. Orio, 2005, The Journal of clinical endocrinology and metabolism.

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

L. Nardo, F. Orio, A. Colao, 2004, Reproductive biomedicine online.

Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome.

F. Manguso, F. Giallauria, C. Vigorito, 2006, The Journal of clinical endocrinology and metabolism.

αANP, AVP, and pituitary-thyroid axis in patients with congestive heart failure and acute respiratory failure

A. Mariano, S. Savastano, G. Lombardi, 1999 .

Adjuvant mitotane treatment for adrenocortical carcinoma.

M. Papotti, P. Bruzzi, M. Fassnacht, 2007, The New England journal of medicine.

Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: Response to chemotherapy and octreotide LAR

A. Colao, M. Pensabene, L. Tauchmanovà, 2005, Journal of endocrinological investigation.

RAPID The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome

L. Nardo, F. Manguso, F. Orio, 2004 .

Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism.

G. Bifulco, G. Lupoli, V. Nuzzo, 2004, Maturitas.

Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass.

G. Lupoli, V. Nuzzo, C. Pizzi, 2001, European journal of endocrinology.

Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients

G. de Rosa, A. Colao, A. Faggiano, 2008, Clinical endocrinology.

Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study

A. Cailleux, D. Hörsch, F. Borson‐Chazot, 2018, Cancer Chemotherapy and Pharmacology.

Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence.

G. Vitale, F. Orio, A. Colao, 2004, The Journal of clinical endocrinology and metabolism.

Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

J. Schopohl, M. Roughton, K. Yuen, 2019, Pituitary.

Cushing's syndrome: aftermath of the cure.

M. D. De Martino, A. Faggiano, A. Colao, 2007, Arquivos brasileiros de endocrinologia e metabologia.

Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies.

G. Bifulco, C. Nappi, F. Orio, 2003, Human reproduction.

Combination of pasireotide and octreotide: effects on GH and IGF-I secretion and glucose metabolism in healthy volunteers

H. Schmid, L. Tauchmanovà, Astrid Breitschaft, 2021, Endocrine.

GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome

C. Nappi, F. Orio, A. Colao, 2003, Journal of endocrinological investigation.

MEN1 family with a novel frameshift mutation

S. Piantadosi, M. Brandi, A. Faggiano, 2006, Journal of endocrinological investigation.

Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.

L. del Viscovo, V. Nuzzo, G. Lombardi, 2000, The Journal of clinical endocrinology and metabolism.

Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.

M. C. Savanelli, G. Lombardi, L. Tauchmanovà, 2005 .

Somatopause: dismetabolic and bone effects.

M. C. Savanelli, G. Lombardi, C. Di Somma, 2005, Journal of endocrinological investigation.

Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism.

A. Colao, I. Chiodini, A. Scillitani, 2002, The Journal of clinical endocrinology and metabolism.

Large idiopathic unilateral adrenal hematoma in a young woman

G. Lombardi, L. Tauchmanovà, R. Rossi, 2007, Journal of endocrinological investigation.

Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocortical adenoma.

S. Savastano, G. Lombardi, L. Tauchmanovà, 1995, European journal of endocrinology.

Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraganglioma

L. Pagano, B. Biondi, G. Lombardi, 2004, Journal of endocrinological investigation.

Circulating ghrelin concentrations in the polycystic ovary syndrome.

F. Orio, A. Colao, P. Lucidi, 2003, The Journal of clinical endocrinology and metabolism.

Avascular necrosis in long‐term survivors after allogeneic or autologous stem cell transplantation

M. Salvatore, F. Fazioli, A. Colao, 2003, Cancer.

Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells

F. Orio, G. Muscogiuri, A. Colao, 2014, TheScientificWorldJournal.

Cryptozoospermia with normal testicular function after allogeneic stem cell transplantation: a case report.

C. Foresta, G. Lombardi, A. Garolla, 2007, Human reproduction.

High prevalence of endocrine dysfunction in long‐term survivors after allogeneic bone marrow transplantation for hematologic diseases

L. Pagano, F. Orio, A. Colao, 2002, Cancer.

Turner’s syndrome mosaicism 45X/47XXX: An interesting natural history

G. Lombardi, L. Tauchmanovà, R. Rossi, 2001, Journal of endocrinological investigation.

Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism

S. Savastano, G. Lombardi, L. Tauchmanovà, 2001, Journal of endocrinological investigation.

Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome.

F. Orio, A. Colao, S. Savastano, 2003, The Journal of clinical endocrinology and metabolism.

Andrenocortical Carcinomas: Twelve-year Prospective Experience

M. Salvatore, A. Colao, G. Lombardi, 2004, World Journal of Surgery.

Thyroid function and morphology after a successful kidney transplantation

M. Sabbatini, S. Federico, F. Orio, 2006, Journal of endocrinological investigation.

Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation.

A. Colao, G. Lombardi, B. Rotoli, 2005, The Journal of clinical endocrinology and metabolism.

Efficacy and safety of osilodrostat in patients with Cushings disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase

X. Bertagna, M. Fleseriu, R. Leelawattana, 2021, Yearbook of Paediatric Endocrinology.

Bone Turnover and the Osteoprotegerin–RANKL Pathway in Tumor-Induced Osteomalacia: A Longitudinal Study of Five Cases

F. Gianfrancesco, T. Esposito, L. Insabato, 2009, Calcified Tissue International.

Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study

Kim Jung Hee, X. Bertagna, M. Fleseriu, 2019, Endocrine Abstracts.

Pharmacokinetics of osilodrostat following single and multiple doses of osilodrostat in healthy subjects and patients with Cushing's disease

L. Tauchmanovà, C. Darstein, Kevin Han, 2019, Endocrine Abstracts.

OR16-2 Osilodrostat Treatment in Cushing's Disease (CD): Results from a Phase III, Multicenter, Double-Blind, Randomized Withdrawal Study (LINC 3)

X. Bertagna, M. Fleseriu, R. Leelawattana, 2019, Journal of the Endocrine Society.

SAT-443 Osilodrostat Has No Clinically Relevant Effect on the Pharmacokinetic (PK) Profile of a Monophasic Oral Contraceptive in Healthy Females Receiving Cortisol Replacement Therapy

H. Nauwelaerts, L. Tauchmanovà, Astrid Breitschaft, 2019, Journal of the Endocrine Society.

Cushing ’ s Syndrome : Aftermath of the Cure ROSARIO PIVONELLO

A. Faggiano, A. Colao, G. Lombardi, 2022 .

Low 25-hydroxyvitamin D levels and low bone density assessed by quantitative ultrasonometry in a cohort of postmenopausal Italian nuns.

V. Nuzzo, A. Colao, L. Tauchmanovà, 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease

A. Tabarin, M. Fleseriu, M. Gadelha, 2019, European journal of endocrinology.

Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women.

M. Sabbatini, S. Federico, F. Orio, 2004, Human reproduction.

Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a doubleblind, randomised withdrawal phase.

X. Bertagna, M. Fleseriu, R. Leelawattana, 2020, The lancet. Diabetes & endocrinology.

Thyroid dysfunction after autologous hematopoietic stem cell transplant.

A. Colao, B. Rotoli, C. Selleri, 2006, The American journal of medicine.

Effects of neridronate treatment in elderly women with osteoporosis

C. Nappi, F. Orio, G. Lombardi, 2005, Journal of endocrinological investigation.

Estrogen-progestogen induced hematocolpometra following allogeneic stem cell transplant.

G. Bifulco, C. Nappi, A. Colao, 2004, Gynecologic oncology.

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.

F. Orio, A. Colao, F. Zullo, 2004, The Journal of clinical endocrinology and metabolism.

Late-night salivary cortisol (LNSC) levels in a Phase III study of long-acting pasireotide in patients with Cushing's disease (CD)

A. Tabarin, M. Fleseriu, M. Gadelha, 2018 .

Predictors of response to long-acting pasireotide in patients with Cushing's disease during a Phase III study

M. Roughton, A. Lacroix, B. Biller, 2018 .

Long-term efficacy and safety of once-monthly pasireotide in patients with Cushing's disease: A Phase III extension study

M. Fleseriu, M. Roughton, J. Newell-Price, 2018 .

Idiopathic chronic urticaria and thyroid autoimmunity

A. Colao, L. Tauchmanovà, A. Zuccoli, 2011, Dermato-endocrinology.

Incidence and pathological characteristics of prostate cancer in Italy: a contribution to the screening debate.

M. Di Maio, L. Tauchmanovà, A. Contegiacomo, 2006, Cancer detection and prevention.

Results from phase 3 study of 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).

J. Bernhard, B. Shuch, A. Pantuck, 2023, Journal of Clinical Oncology.

TAG-72 expression and clinical outcome in primary breast cancer.

R. Mariani-Costantini, R. Muraro, A. Bianco, 1999, Oncology reports.

The role for growth hormone in linking arthritis, osteoporosis, and body composition.

A. Colao, G. Lombardi, C. Di Somma, 2007, Journal of Endocrinological Investigation.

Comment on 'Cancer genetic counselling' by P. Mandich et al. (Ann Oncol 2005; 16: 171).

S. Venuta, V. Barbieri, E. Ricevuto, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation

C. Nappi, F. Orio, G. Lombardi, 2006, Bone Marrow Transplantation.

Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

J. Schopohl, M. Roughton, K. Yuen, 2019, Pituitary.

A novel mutation in the N-terminal region of the CYP17A1 gene in a patient with 17α-hydroxylase/17,20-lyase deficiency

N. Brunetti‐Pierri, G. Lupoli, A. Colao, 2009, Journal of endocrinological investigation.

British Nuclear Medicine Society Autumn Meeting 2023.

A. Pantuck, D. Gramberg, L. Livieratos, 2023, Nuclear medicine communications.

Long-term safety and efficacy of subcutaneous pasireotide in Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing's disease: interim results from a long-term patients with Cushing's disease: interim results from a long-term real-world evidence study. real-world evidence

L. Tauchmanovà, U. Kriemler-Krahn, R. Maamari, 2022 .